Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors
MENLO PARK, Calif. and BOSTON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering...
News
Applied Therapeutics to Present at the 14th International Congress of Inborn Errors of Metabolism
NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline...
CLS Again Releases TRANBERG® Sterile Disposable Products into the US Market
IRVINE, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal...
Orchard Therapeutics Announces New England Journal of Medicine Publication of Interim Proof-of-concept Study Results of OTL-203 for Hurler Syndrome
100 percent overall survival with median follow-up of two years post-treatment with HSC gene therapy Preliminary findings show promising metabolic...
CLS Again Releases TRANBERG® Sterile Disposable Products into the US Market
LUND, Sweden, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal...
Matinas BioPharma to Participate in 33rd Annual Piper Sandler Virtual Healthcare Conference
BEDMINSTER, N.J., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on...
Medicenna Receives Award for Excellence in Clinical Trials in Connection with an Upcoming Presentation at the 26th Annual Meeting of the Society for Neuro-Oncology
TORONTO and HOUSTON, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA),...
The Lancet Neurology Publishes Pivotal Phase 3 PROPEL Study Results of AT-GAA in Late-Onset Pompe Disease
Peer Reviewed Results from PROPEL Show Treatment with AT-GAA Provided Clinically Meaningful Improvements Over Standard of Care, including ERT Experienced...
NervGen Pharma Reports Third Quarter 2021 Results
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),...
PreveCeutical Signs License Agreement for Exclusive Rights to Use UniQuest’s Sol-Gel Technology for Delivery of Cannabinoids
Vancouver, British Columbia--(Newsfile Corp. - November 18, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) ("PreveCeutical" or the "Company"),...
Northeastern Center Selects Streamline’s SmartCare As Their Next Electronic Health Record (EHR)
OAKBROOK TERRACE, Ill.--(BUSINESS WIRE)--Following a comprehensive evaluation, Northeastern Center, headquartered in Kendallville, Indiana, has selected Streamline Healthcare Solutions (Streamline) as...
Outset Medical Named to Fast Company’s First-Ever List of the Next Big Things in Tech
New Recognition Program Highlights Tech Breakthroughs That Promise to Define the Future of Their Industries SAN JOSE, Calif.--(BUSINESS WIRE)--#BetterBeginsNow--Outset Medical,...
NextGen Healthcare Partners with Prominent Psychiatrist Dr. Gail Saltz to Shine Light on Mental Health Support
#NextGenMind Campaign Supports Mental Health Awareness to Pave Path to Whole-Person Health, Starting with a Live Open-to-the-Public Q&A Session ATLANTA--(BUSINESS...
Telemetrix and Rx.Health to Create a Unified Solution for RPM and RTM
Allows remote physiologic and therapeutic monitoring to be prescribed from the EHR system ATLANTA & NEW YORK--(BUSINESS WIRE)--#RPM--Telemetrix, the premier...
Keyavi Data Wins Fast Company’s First-Ever Next Big Things in Tech Award
Cybersecurity Trailblazer Honored for Groundbreaking Innovation Defining the Future of Data Security DURANGO, Colo.--(BUSINESS WIRE)--#B2B--Keyavi Data Corp., a cybersecurity trailblazer...
Evotec and EQRx Announce Integrated Drug Discovery and Development Partnership
EQRX TO LEVERAGE EVOTEC'S UNIQUE DATA-DRIVEN INTEGRATED DRUG DISCOVERY AND DEVELOPMENT ACCELERATOR PLATFORMPARTNERSHIP AIMS TO BUILD UP JOINTLY OWNED PIPELINE...
Relief Therapeutics Launches Level 1 ADR Program in the United States
GENEVA, SWITZERLAND / ACCESSWIRE / November 18, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF) (" Relief "), announced today...
EMulate Therapeutics Announces the Incorporation of Two Wholly Owned Subsidiaries
EMulate Therapeutics Has Incorporated Two Wholly Owned Subsidiaries to Deploy Its Platform Technology for the Treatment of Pain Management and...
Accenture and Organon Team Up to Drive Digital Transformation for Better Patient and Employee Experiences
Accenture to help build Organon’s next generation enterprise capabilities with SAP S4/HANA® on AWS NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has...
ExdionACE Platform Revolutionizes Use of Artificial Intelligence in Medical Coding
Platform Can Increase Revenues for Most Medical Practices Without Audit Risk PLANO, Texas--(BUSINESS WIRE)--#ai--A new AI-driven optimization platform developed by...